HCV-ITEM: Human anti-Coronavirus vaccine that induces Specific Tecidual Immunity Multi-Epitope (Q2867174)

From EU Knowledge Graph
Revision as of 13:40, 21 October 2021 by DG Regio (talk | contribs) (‎Removed claim: budget (P474): 470,365.24 euro)
Jump to navigation Jump to search
Project Q2867174 in Portugal
Language Label Description Also known as
English
HCV-ITEM: Human anti-Coronavirus vaccine that induces Specific Tecidual Immunity Multi-Epitope
Project Q2867174 in Portugal

    Statements

    0 references
    1 May 2020
    0 references
    28 February 2021
    0 references
    IMMUNETHEP, S.A.
    0 references
    0 references

    40°21'55.76"N, 8°39'29.95"W
    0 references
    Face à pandemia de COVID-19 e consequente urgência de soluções terapêuticas, o projeto VHC-ITEM visa a criação e prova de conceito de uma vacina inovadora, de aplicação intranasal, capaz de conferir elevada imunogenicidade face a potenciais mutações do vírus, pela utilização de SARS-CoV-2 atenuado. (Portuguese)
    0 references
    In view of the COVID-19 pandemic and consequent urgency of therapeutic solutions, the HCV-ITEM project aims to create and test the concept of an innovative vaccine, of intranasal application, capable of conferring high immunogenicity in the face of potential mutations of the virus, through the use of attenuated SARS-CoV-2. (English)
    7 July 2021
    0 references
    Cantanhede
    0 references

    Identifiers

    CENTRO-01-02B7-FEDER-060491
    0 references